放射腫瘤市場按治療方法、技術、應用、最終用戶和地區分類

預計到 2025 年，放射腫瘤學市場價值將達到 125.1 億美元，預計到 2032 年將達到 163.1 億美元，2025 年至 2032 年的複合年成長率為 11.2%。

全球放射腫瘤市場是醫療產業的重要組成部分，涵蓋了透過精準放射治療系統進行癌症治療的先進醫療技術和治療方案。放射腫瘤學是一門利用高能量放射線束摧毀癌細胞，同時最大限度地減少對周圍健康組織損傷的醫學專科，使其成為全面癌症治療通訊協定的重要組成部分。該市場包含各種先進設備，例如線性加速器、近距離放射機、質子治療系統和立體定位放射放射線手術機，以及支援治療計劃和患者管理的軟體解決方案。

人口老化、生活方式改變和環境因素導致全球癌症負擔日益加重，使得放射腫瘤學成為現代癌症治療的基石。世界各地的醫療機構都在大力投資最先進的放射治療設備，以提高治療精度、減少副作用並改善患者預後。這個市場發展的特點是技術的不斷進步，例如影像導航放射治療（IGRT）、強度調控放射治療（IMRT）以及人工智慧的融合應用，這些技術共同促成了更個人化和有效的癌症治療方法，使放射腫瘤學成為全球醫療保健領域中一個至關重要且快速發展的領域。

市場動態

全球放射腫瘤市場受多種強勁因素驅動，維持穩健的成長動能。其中，全球癌症發生率的不斷攀升是主要促進因素，這需要複雜的治療性介入，並導致全球醫療機構對先進放射治療設備的需求顯著成長。人口老化也是關鍵的人口因素，癌症發生率隨年齡成長而顯著上升，從而持續推動醫院和專科癌症治療中心對放射腫瘤服務和設備升級的需求。技術創新也是重要的成長要素，精準醫療、人工智慧整合、影像導航放射治療和質子治療等領域的突破性進展，在提高治療效果的同時降低了副作用，促使醫療機構投資於新一代放射腫瘤解決方案。

然而，市場也面臨許多阻礙因素。購置和安裝先進放射治療設備所需的高昂資本成本，尤其會對醫療預算造成巨大壓力，並限制新興市場和小規模醫療機構的普及率。此外，合格的放射腫瘤科醫師、醫學物理學家和訓練有素的技術人員短缺，也造成了營運方面的限制，阻礙了市場擴張。而且，新放射治療技術嚴格的監管核准流程可能會延遲產品上市和市場滲透。儘管有這些挑戰，但由於許多機會，放射腫瘤市場預計將維持長期持續成長。這些機會包括開發中國家醫療基礎設施的擴建、政府主導的癌症治療改善計劃的增加、針對先進癌症治療的醫療旅遊的興起，以及提高治療效率和患者便利性的分次放射治療技術的廣泛應用。

本次調查的主要特點

• 本報告對全球放射腫瘤市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和復合年成長率（%）。
• 它重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
• 該報告根據以下參數對全球放射腫瘤學市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、設備升級、市場擴張和行銷策略做出明智的決策。
• 這份全球放射腫瘤市場報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過各種用於分析全球放射腫瘤市場的策略矩陣，更輕鬆地做出決策。

目錄

第1章 研究目標與前提條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場範圍

• 報告概述
  • 市場定義和範圍
• 執行摘要

第3章 市場動態、監理及趨勢分析

• 市場動態
• 促進要素
• 抑制因素
• 機會
• 影響分析
• 重大進展
• 法規環境
• 產品上市及核准
• PEST分析
• 波特分析
• 併購趨勢
• 產業趨勢

4. 2020-2032年全球放射腫瘤市場（依治療方法）

• 體外放射治療（EBRT）
• 體內放射治療（近距離放射治療/體內照射）
• 質子束/重粒子束療法
• 放射性藥物和全身放射線治療

5. 2020-2032年全球放射腫瘤市場（依技術分類）

• 3D適形放射治療（3D CRT）
• 強度調控放射治療（IMRT）
• 容積調強弧形治療（VMAT）
• 影像導航放射治療（IGRT）
• 立體定位放射治療（SRS/SBRT）
• 高劑量率（HDR）/低劑量率（LDR）近距離放射
• 自適應放射治療/即時腫瘤追蹤

6. 2020-2032年全球放射腫瘤市場（依應用領域分類）

• 乳癌
• 肺癌
• 攝護腺癌
• 頭頸癌
• 大腸直腸癌
• 婦科癌症
• 其他癌症（例如，皮膚癌、腦瘤、胰臟癌、罕見腫瘤等）

7. 2020-2032年全球放射腫瘤市場（依最終用戶分類）

• 醫院（癌症及放射治療科）
• 專業腫瘤及放射治療中心
• 門診放射治療診所
• 研究機構和大學

8. 2020-2032年全球放射腫瘤市場（依地區分類）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太其他地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第9章 競爭情勢

• Varian Medical Systems Inc.
• Elekta AB
• Accuray Incorporated
• Mevion Medical Systems
• ViewRay Technologies Inc.
• Isoray Inc.
• Hitachi Ltd.
• IBA（Ion Beam Applications SA）
• Nordion Inc.
• Brainlab SE
• Xstrahl Ltd.
• Panacea Medical Technologies Pvt. Ltd.
• Siemens Healthineers AG
• GE HealthCare
• Bionix Radiation Therapy LLC

第10章 分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第11章 參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Radiation Oncology Market is estimated to be valued at USD 12.51 Bn in 2025 and is expected to reach USD 16.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.

The global radiation oncology market represents a critical segment of the healthcare industry, encompassing advanced medical technologies and therapeutic solutions designed to combat cancer through precise radiation delivery systems. Radiation oncology, as a specialized field of medicine, utilizes high-energy radiation beams to destroy malignant cells while minimizing damage to surrounding healthy tissues, making it an indispensable component of comprehensive cancer treatment protocols. This market encompasses a diverse array of sophisticated equipment including linear accelerators, brachytherapy devices, proton therapy systems, and stereotactic radiosurgery units, alongside supporting software solutions for treatment planning and patient management.

The increasing global cancer burden, driven by aging populations, lifestyle changes, and environmental factors, has positioned radiation oncology as a cornerstone of modern oncological care. Healthcare institutions worldwide are investing substantially in state-of-the-art radiation therapy equipment to enhance treatment precision, reduce side effects, and improve patient outcomes. The market's evolution is characterized by continuous technological advancements, including image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and artificial intelligence integration, which collectively contribute to more personalized and effective cancer treatment approaches, establishing radiation oncology as an essential and rapidly expanding segment within the global healthcare landscape.

Market Dynamics

The global radiation oncology market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, primarily anchored by the escalating global cancer incidence rates, which necessitate advanced therapeutic interventions and drive substantial demand for sophisticated radiation therapy equipment across healthcare facilities worldwide. The aging global population presents a significant demographic driver, as cancer prevalence increases substantially with age, creating sustained demand for radiation oncology services and equipment upgrades in hospitals and specialized cancer treatment centers. Technological innovations serve as another pivotal growth driver, with breakthrough developments in precision medicine, artificial intelligence integration, image-guided radiation therapy, and proton beam therapy enhancing treatment efficacy while reducing adverse effects, thereby encouraging healthcare institutions to invest in next-generation radiation oncology solutions.

However, the market faces notable restraints including the exceptionally high capital costs associated with acquiring and installing advanced radiation therapy equipment, which can strain healthcare budgets and limit adoption rates, particularly in emerging markets and smaller healthcare facilities. Additionally, the shortage of qualified radiation oncologists, medical physicists, and trained technicians creates operational constraints that can impede market expansion, while stringent regulatory approval processes for new radiation therapy technologies can delay product launches and market penetration. Despite these challenges, significant opportunities emerge from the expanding healthcare infrastructure in developing nations, increasing government initiatives for cancer care improvement, growing medical tourism for advanced cancer treatments, and the rising adoption of hypofractionated radiation therapy techniques that improve treatment efficiency and patient convenience, positioning the radiation oncology market for sustained long-term growth.

Key Features of the Study

• This report provides in-depth analysis of the global radiation oncology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global radiation oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems, ViewRay Technologies Inc., Isoray Inc., Hitachi Ltd., IBA (Ion Beam Applications SA), Nordion Inc., Brainlab SE, Xstrahl Ltd., Panacea Medical Technologies Pvt. Ltd., Siemens Healthineers AG, GE HealthCare, and Bionix Radiation Therapy LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global radiation oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiation oncology market

Market Segmentation

• Therapy Type Insights (Revenue, USD Bn, 2020 - 2032)
  • External Beam Radiation Therapy (EBRT)
  • Internal Beam Radiation Therapy (Brachytherapy/Internal)
  • Proton and Heavy Ion Therapy
  • Radiopharmaceutical and Systemic Radiation Therapy
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • 3D Conformal Radiotherapy (3D CRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Image Guided Radiotherapy (IGRT)
  • Stereotactic Radiotherapy (SRS/SBRT)
  • High Dose Rate (HDR)/Low Dose Rate (LDR) Brachytherapy
  • Adaptive Radiotherapy/Real Time Tumor Tracking
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Head and Neck Cancer
  • Colorectal Cancer
  • Gynecologic Cancers
  • Other Cancers (e.g., skin, brain, pancreas, rare tumors)
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals (Cancer/Radiation Therapy Departments)
  • Dedicated Oncology and Radiotherapy Centers
  • Ambulatory/Outpatient Radiotherapy Clinics
  • Research and University Institutes
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Varian Medical Systems Inc.
  • Elekta AB
  • Accuray Incorporated
  • Mevion Medical Systems
  • ViewRay Technologies Inc.
  • Isoray Inc.
  • Hitachi Ltd.
  • IBA (Ion Beam Applications SA)
  • Nordion Inc.
  • Brainlab SE
  • Xstrahl Ltd.
  • Panacea Medical Technologies Pvt. Ltd.
  • Siemens Healthineers AG
  • GE HealthCare
  • Bionix Radiation Therapy LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Radiation Oncology Market, By Therapy Type
  • Global Radiation Oncology Market, By Technology
  • Global Radiation Oncology Market, By Application
  • Global Radiation Oncology Market, By End User
  • Global Radiation Oncology Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Radiation Oncology Market, By Therapy Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• External Beam Radiation Therapy (EBRT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Internal Beam Radiation Therapy (Brachytherapy/Internal)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Proton and Heavy Ion Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Radiopharmaceutical and Systemic Radiation Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Radiation Oncology Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• 3D Conformal Radiotherapy (3D CRT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intensity Modulated Radiotherapy (IMRT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Volumetric Modulated Arc Therapy (VMAT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Image Guided Radiotherapy (IGRT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Stereotactic Radiotherapy (SRS/SBRT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• High Dose Rate (HDR)/Low Dose Rate (LDR) Brachytherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Adaptive Radiotherapy/Real Time Tumor Tracking
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Radiation Oncology Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Breast Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Lung Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prostate Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Head and Neck Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Colorectal Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gynecologic Cancers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Cancers (e.g., skin, brain, pancreas, rare tumors)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Radiation Oncology Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals (Cancer/Radiation Therapy Departments)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dedicated Oncology and Radiotherapy Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory/Outpatient Radiotherapy Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research and University Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Radiation Oncology Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Varian Medical Systems Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Elekta AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Accuray Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mevion Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ViewRay Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Isoray Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hitachi Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IBA (Ion Beam Applications SA)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nordion Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Brainlab SE
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Xstrahl Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Panacea Medical Technologies Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE HealthCare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bionix Radiation Therapy LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us